Abu Dhabi- October 2024- Under the Patronage of His Highness Sheikh Mansour bin Zayed Al Nahyan, Vice President, Deputy Prime Minister and Chairman of the Presidential Court, the 2nd annual ADSCC Bone Marrow Transplant and Cellular Therapy Congress 2024, organized by Abu Dhabi Stem Cells Center (ADSCC) will take place in Abu Dhabi from October 26 to 27 at Rixos Marina Abu Dhabi.
Building on the success of its inaugural edition in November 2023, which drew over 1,300 delegates from the healthcare sector and patients, this prestigious global health conference now enters its second edition, uniting leading experts, researchers, scientists, and practitioners worldwide to discuss the latest advancements and innovations in bone marrow transplant, cellular therapy, and regenerative medicine.
Supporting the strategic vision of ADSCC towards revolutionising healthcare globally, the congress hosts more than 35 international speakers from the US, Japan, UK, Germany, Spain, Switzerland, Italy, Singapore and the Middle East alongside 25 local speakers from prominent institutions in the UAE. Until today, more than 2,000 delegate registered to attend the congress, which is supported by the Department of Culture and Tourism – Abu Dhabi, and endorsed by international institutions including Boston Children’s Hospital, Indiana University Health and Josep Carreras Leukaemia Research Institute; academic partners including UAE University and Khalifa University, in addition to various medical societies including Emirates Oncology Society and UAE Rare Disease Society.
Also Read: ADSCC Performs UAE’s First Paediatric Ovarian Preservation for Young Leukaemia Patient
As a platform to showcase UAE’s recent advancements in cellular therapies, participants will have the chance to showcase pioneering research, present case studies and engage in interactive sessions driving innovation in the field.
The congress targets physicians in hematology, oncology, bone marrow transplant, and apheresis, as well as researchers, scientists, and clinicians interested in regenerative medicine. It also welcomes nurses, medical students, academic faculty, and pharmacists.
Prof. Yendry Ventura, CEO of ADSCC, stated: “Within the rapidly evolving healthcare landscape, ADSCC remains firmly dedicated to advancing innovative care and research that align with the UAE’s leadership directives. Our upcoming event in Abu Dhabi, held under the esteemed patronage of His Highness Sheikh Mansour bin Zayed Al Nahyan, reflects our commitment toward education and knowledge sharing in the field of cellular therapy.”
Dr. Fatima Al Kaabi, Congress President and Executive Director of the Abu Dhabi Bone Marrow Transplant program at ADSCC, added, “As we bring together global leaders in the field at this congress, we are confident that our collective efforts will drive significant progress in the fight against diseases that demand advanced treatment solutions such as blood disorders, autoimmune diseases, neurological disorders and others.”
Day 1
On its first day, the congress will host a Roundtable Session featuring prominent healthcare CEOs in UAE, focusing on Artificial Intelligence in Healthcare, setting the tone for the innovative discussions to follow. The day unfolds into a series of specialized sessions covering topics such as CAR-T treatment updates, challenges in myeloid malignancies, longevity and health, stem cells therapy in neurological disorders, cellular therapy for autoimmune diseases, and the fascinating world of induced pluripotent stem cells.
Day 2
The second day will continue the momentum with a Roundtable Session on Immunotherapy in Cancer, followed by diverse sessions on fertility preservation and restoration, advancements in treating lymphoma, myeloma, and amyloid disorders, and the promising field of gene therapy in haemoglobinopathies. The day also explores cellular therapy in solid tumors, the latest in GVHD management, and the practical applications of regenerative medicine in clinical settings. A standout feature of this conference is its inclusion of nursing-focused sessions, recognizing the vital role of nursing professionals in bone marrow transplantation.
